The value of the use of biotechnology: public views in China and Europe

Abstract

This study contrasts public views of the value of biotechnology applications in China and Europe. The most striking result is that biotechnology applications get more consistent acceptance and support in China than in Europe. The Chinese people are extremely positive in their evaluation of the usefulness and moral acceptability of various applications of biotechnology, whereas the European public has broader and firmer understanding of the risks involved. Furthermore, the findings indicate that the public's perception of benefit might be a prerequisite to supporting the development of biotechnology; nevertheless, moral acceptance is the key to gaining public support. Conversely, public perceptions of high risk may not necessarily reduce the level of support.